Interventional Cardiology Market, By Type (Balloons, Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others), System (Fractional Flow Reserve (FFR) System, Intravascular Ultrasound (IVUS) Systems, Optical Coherence Tomography (OCT) Systems), End Users (Hospitals, Surgical Centers, Cardiac Centers, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global interventional cardiology market is anticipated to reach USD 25.93 billion by 2020 growing at a CAGR of 7.9% during the forecasting period, 2020-2028. Interventional cardiology is the cardiology which deals with the catheter-based treatment of structural heart diseases. It helps in the avoidance of scars and pain, and long post-operative recovery. Factors such as the rising geriatric population due to higher life expectancy and increasing clinical evidence of the effectiveness of advanced interventional cardiac devices are some of the major drivers for the interventional cardiology market
The global interventional cardiology market is segmented into type, system, end-user, and geography.
The type segment is segmented into Balloons, Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others
System segment is segmented into Fractional Flow Reserve (FFR) System, Intravascular Ultrasound (IVUS) Systems and Optical Coherence Tomography (OCT) Systems
End Users segment is segmented into Hospitals, Surgical Centers, Cardiac Centers, and Others
Geographically, the global interventional cardiology market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions.
North America region is the largest contributor to the interventional cardiology market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.
Key players in the global interventional cardiology market are Abiomed, Inc., ACIST Medical Systems, Inc., B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Life Vascular Devices Biotech S.L., Biostense Webster, Inc., Medtronic Plc, Merit Medical Systems, Inc., Novacam Technologies Inc., Koninklijke Philips N.V., St. Jude Medical, Terumo Corporation, and W.L. Gore & Associates, Inc among others
The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:
Hence, tremendous progress has been made over the last decade and yet a lot more to come in the recent years
Report Features |
Description |
---|---|
Market Revenue In 2020 |
USD 25.93 billion |
Growth Rate |
CAGR of 7.9% during the forecasting period, 2020-2028 |
Historical Data |
2017-2018 |
Forecast Years |
2020-2028 |
Base Year |
2019 |
Units Considered |
Revenue in USD billion and CAGR from 2020 to 2028 |
Report Segmentation |
Type, System, End-User, and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Abiomed, Inc., ACIST Medical Systems, Inc., B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Life Vascular Devices Biotech S.L., Biostense Webster, Inc., Medtronic Plc, Merit Medical Systems, Inc., Novacam Technologies Inc., Koninklijke Philips N.V., St. Jude Medical, Terumo Corporation, and W.L. Gore & Associates, Inc among others |
Available Customization |
In addition to the market data for the interventional cardiology market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements. |